The Company expects to submit the New Drug Application for Xulane Lo in the second half of 2025. A low dose combination hormonal patch was found to be effective for pregnancy prevention based on ...
PITTSBURGH, May 8, 2025 /PRNewswire/ -- Viatris Inc. (VTRS) (Nasdaq: VTRS), a global healthcare company, today announced positive results of its Phase 3 study (NCT05139121) evaluating the ...
This is the fifth installment in a series of articles about the science of various aspects of college life. Any Brown student can schedule an appointment with Student Health Services to review various ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback